ALDX SCHEDULE 13G/A: SEC filing
AQR Capital Management LLC
Filed with the SEC on · accession 0001167557-26-000229
ALDX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 12, 2026. AQR Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 672,616 shares, or 1.11%, of Aldeyra Therapeutics common stock as of September 30, 2026.
Summary of the filing
AQR Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 672,616 shares, or 1.11%, of Aldeyra Therapeutics common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure with no stated intent to influence control.
Key details
✦ Ask GOAX AI about this filing — what it means for ALDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for ALDX?
Click hereFrequently asked questions
What did ALDX file with the SEC on Nov 12, 2026?
ALDX filed a SCHEDULE 13G/A (SEC filing). AQR Capital Management LLC filed an amended Schedule 13G reporting beneficial ownership of 672,616 shares, or 1.11%, of Aldeyra Therapeutics common stock as of September 30, 2026. The filing is a passive institutional ownership disclosure with no stated intent to influence control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other ALDX SEC filings
- 8-K · Regulatory actionNov 9, 2026
- SCHEDULE 13G · SEC filingNov 6, 2026
- 10-Q · SEC filingNov 5, 2026
- 8-K · Regulatory actionSep 29, 2026
- SCHEDULE 13G · SEC filingAug 12, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Material agreementJul 30, 2026
- 8-K · Fda approvalJul 15, 2026
- 8-K · Board changeJun 10, 2026
- 10-Q · SEC filingMay 7, 2026
Get alerts when ALDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days